Anthony Jay Dulgeroff MD
Diabetes, Lipid Metabolism
Associate Medical Director High Desert Medical Group
Join to view full profile
43839 15th St WLancaster, CA 93534
Phone+1 661-945-5984
Fax+1 661-948-1574
Dr. Dulgeroff is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Anthony Dulgeroff is an endocrinologist based in Lancaster, CA, with subspecialties in diabetes and lipid metabolism. He graduated from the Keck School of Medicine of USC in 1988 and completed his residency and fellowship at UCLA-VA Greater Los Angeles. He has been serving as the Associate Medical Director at High Desert Medical Group since 1995. Dr. Dulgeroff has authored publications in esteemed journals, with his work on thyroid conditions being notably cited. He has received CMS Meaningful Use certifications for his use of NextGen Ambulatory EHR.
Education & Training
UCLA-VA Greater Los AngelesFellowship, Endocrinology, Diabetes, and Metabolism, 1991 - 1993- UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1988 - 1991
Keck School of Medicine of the University of Southern CaliforniaClass of 1988
Certifications & Licensure
CA State Medical License 1990 - 2027
AZ State Medical License 1993 - 1999
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013-2015, 2017
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013-2015, 2017
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Publications & Presentations
PubMed
- 53 citationsMedical Therapy for Differentiated Thyroid CarcinomaAnthony J. Dulgeroff, Jerome M. Hershman
Endocrine Reviews. 1994-08-01 - 35 citationsBromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone.A J Dulgeroff, Mitchell E. Geffner, S N Koyal, M Wong, Jerome M. Hershman
The Journal of Clinical Endocrinology and Metabolism. 1992-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
